Muna Therapeutics Competitors and Similar CompaniesClear all

Muna Therapeutics's competitors and similar companies include Acorda Therapeutics, Codiak Biosciences, VCANBIO and Cellares.

	Muna Therapeutics Muna Therapeutics is a provider of transformative therapeutics to preserve brain function and enhance resilience to neurodegenerative diseases.	Acorda Therapeutics Acorda Therapeutics is a biotechnology company focused on developing therapies that restore function and improve the lives of people with neurological disorders.	Codiak Biosciences Codiak Biosciences is a biopharmaceutical company focused on the development of exosome-based therapeutics.	VCANBIO VCANBIO Cell & Gene Engineering (also known as Zhongyuan Union) is a biotech company that offers health management services and products.	Cellares Cellares is a provider of cell therapy manufacturing services.
Founding Date	Founding Date 2020	Founding Date 1995	Founding Date 2015	Founding Date 1993	Founding Date 2019
Type	Type Subsidiary	Type Public	Type Public	Type Public	Type Private
Tags	Tags Healthcare biotech therapy	Tags Healthcare biotech therapy	Tags Healthcare biotech therapy	Tags Healthcare biotech medical diagnostics platform therapy	Tags Healthcare biotech therapy
Locations	Locations København, DK HQ	Locations Ardsley, US HQ Chelsea, US South San Francisco, US Waltham, US	Locations Cambridge, US HQ	Locations Tianjin, CN HQ	Locations South San Francisco, US HQ
Employees	Employees 55	Employees 4742% decrease	Employees 992% decrease	Employees 2,0149% decrease	Employees 2613% increase
Valuation ($)	Valuation ($) N/A	Valuation ($) 821 k	Valuation ($) 2.8 m	Valuation ($) 1.4 b	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $117.6m (FY, 2023)	Revenue (est.) $22.9m (FY, 2021)	Revenue (est.) ¥1.4b (FY, 2025)	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods $15.3m (FY, 2023)	Cost of goods N/A	Cost of goods ¥438.8m (FY, 2025)	Cost of goods N/A
Net income	Net income N/A	Net income ($252.9m) (FY, 2023)	Net income ($37.2m) (FY, 2021)	Net income ¥103.5m (FY, 2025)	Net income N/A

For sources of this data, please see the company profile

View Company Profiles

Acorda Therapeutics

Ardsley, US

Employees

474↓ 2% decrease

Acorda Therapeutics is a biotechnology company focused on developing therapies that restore function and improve the lives of people with neurological disorders.

View company

Codiak Biosciences

Cambridge, US

Employees

99↓ 2% decrease

Codiak Biosciences is a biopharmaceutical company focused on the development of exosome-based therapeutics.

View company

VCANBIO

Tianjin, CN

Employees

2,014↓ 9% decrease

VCANBIO Cell & Gene Engineering (also known as Zhongyuan Union) is a biotech company that offers health management services and products.